Alport syndrome is a rare, genetic form of CKD caused by mutations in the genes encoding type IV collagen, which is a major structural component of the glomerular basement membrane in the kidney.

Alport syndrome is a hereditary kidney disorder characterized by hematuria and proteinuria that begin in childhood and progressively lead to renal impairment. The disease results from mutations in ...

Add Yahoo as a preferred source to see more of our stories on Google. ASHLAND A very rare genetic disease is taking its toll on a local family. Amanda Liles lives in Lewis County and worked in Ashland ...

WATERTOWN, Mass., June 21, 2023 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today highlighted recent Alport ...

Eloxx recently announced achievement of remission in one patient in its Phase 2 Alport syndrome clinical study and decision to advance into a pivotal trial in Alport syndrome WATERTOWN, Mass., June 21 ...

The Company will initiate a Phase 2 clinical study of Vonafexor in Alport Syndrome - called “ALPESTRIA-1” - in the first half of 2024. Series C proceeds will fund the Phase 2 study, as well as ...

BAY 3401016 is an investigational monoclonal antibody with potential to block a protein called Semaphorin 3A (Sema3A), which is thought to be involved in the progression of kidney damage in Alport ...

The most common first diagnosis of Alport syndrome in Japan is during the universal age-3 urine screening. In 60% of these children, the disease had already progressed far enough to qualify for ...

TOLEDO, Ohio — Maureen and David Smith are beyond proud of their son, 27-year-old Chandler, who was born with Alport Syndrome. Alport Syndrome is a rare genetic illness that numerous people in Maureen ...

TOKYO, Oct. 17, 2025 /PRNewswire/ -- Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; "Renalys") today announced that it has reached an agreement with the Pharmaceuticals and Medical Devices Agency ...